Capital Wealth Planning’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,215
Closed -$292K 156
2023
Q4
$292K Buy
+2,215
New +$292K ﹤0.01% 124